Patents by Inventor Rebecca Norris

Rebecca Norris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Use of thiazolidinedione derivatives in the treatment of insulin resistance

Patent number: 6130216

Abstract: The present invention provides methods of using thiazolidinedione in the treatment of insulin resistance.

Type: Grant

Filed: November 16, 1999

Date of Patent: October 10, 2000

Assignee: Warner-Lambert Company

Inventors: Tammy Antonucci, Dean Lockwood, Rebecca Norris
Use of thiazolidinedione derivatives in the treatment of insulin resistance

Patent number: 6046202

Abstract: The present invention provides methods of using thiazolidinedione in the treatment of insulin resistance.

Type: Grant

Filed: October 8, 1998

Date of Patent: April 4, 2000

Assignee: Warner-Lambert Company

Inventors: Tammy Antonucci, Dean Lockwood, Rebecca Norris
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Patent number: 6046222

Abstract: Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations at risk for developing noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed. In one embodiment, the compounds of the invention are used to treat polycystic ovary syndrome in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus. In another embodiment, the compounds of the invention are used to treat gestational diabetes in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus.

Type: Grant

Filed: June 4, 1997

Date of Patent: April 4, 2000

Assignee: Warner-Lambert Company

Inventors: Tammy Antonucci, Dean Lockwood, Rebecca Norris
Use of thiazolidinedione derivatives in the treatment of anovulation, hyperandrogenism and hirsutism

Patent number: 5972944

Abstract: The present invention provides methods of using thiazolidinone derivatives to treat anovulation, hyperandrogenism and hirsutism.

Type: Grant

Filed: July 29, 1998

Date of Patent: October 26, 1999

Assignee: Warner-Lambert Company

Inventors: Tammy Antonucci, Dean Lockwood, Rebecca Norris
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Patent number: 5874454

Abstract: Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations at risk for developing noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed In one embodiment, the compounds of the invention are used to treat polycystic ovary syndrome in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus. In another embodiment, the compounds of the invention are used to treat gestational diabetes in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus.

Type: Grant

Filed: May 15, 1997

Date of Patent: February 23, 1999

Assignee: Warner-Lambert Company

Inventors: Tammy Antonucci, Dean Lockwood, Rebecca Norris
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Patent number: 5602133

Abstract: Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations at risk for developing noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed. In one embodiment, the compounds of the invention are used to treat polycystic ovary syndrome in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus. In another embodiment, the compounds of the invention are used to treat gestational diabetes in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus.

Type: Grant

Filed: June 6, 1995

Date of Patent: February 11, 1997

Assignee: Warner-Lambert Company

Inventors: Tammy Antonucci, Dean Lockwood, Rebecca Norris
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Patent number: 5478852

Abstract: Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations experiencing impaired glucose intolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed.

Type: Grant

Filed: August 23, 1994

Date of Patent: December 26, 1995

Assignee: Sankyo Company, Limited

Inventors: Jerrold Olefsky, Tammy Antonucci, Dean Lockwood, Rebecca Norris
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Patent number: 5457109

Abstract: Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations at risk for developing noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed. In one embodiment, the compounds of the invention are used to treat polycystic ovary syndrome in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus. In another embodiment, the compounds of the invention are used to treat gestational diabetes in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus.

Type: Grant

Filed: August 23, 1994

Date of Patent: October 10, 1995

Assignee: Warner-Lambert Company

Inventors: Tammy Antonucci, Dean Lockwood, Rebecca Norris